Identification
CAS: 11111-23-2
- Name:
- Lividomycin
- Cas No.:
- 11111-23-2
- Molecular Structure:
-
- EINECS(EC#):
- Molecular Formula:
- Molecular Weight:
- Synonyms:
11111-23-2 Chemical
- Appearance:
- mp :
- bp :
- Flash Point:
- Density:
- Water Solubility :
11111-23-2 Safety Data
Risk Codes:
Safety:
Poison by intravenous route. Moderately toxic by subcutaneous and intramuscular routes. An experimental teratogen. Experimental reproductive effects.
RTECS :
DG0875000
Chemistry
IUPACName:(2R,3S,4S,5S,6R)-2-[(2S,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(2R,3S,4R,5S)-5-[(1R,2R,3S,5R,6S)-3,5-diamino-2-[(2S,3R,5S,6R)-3-amino-5-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-hydroxycyclohexyl]oxy-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]oxy-4-hydroxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triolSynonymsofLividomycin(CASNO.11111-23-2):(1R,2R,3S,4R,6S)-4,6-Diamino-3-hydroxy-2-{[alpha-D-mannopyranosyl-(1->4)-2,6-diamino-2,6-dideoxy-beta-L-idopyranosyl-(1->3)-beta-D-ribofuranosyl]oxy}cyclohexyl2-amino-2,3-dideoxy-alpha-D-ribo-hexopyr;alpha-D-Ribo-hexopyranoside,(1R,2R,3S,4R,6S)-4,6-diamino-3-hydroxy-2-[[O-alpha-D-mannopyranosyl-(1->4)-O-2,6-diamino-2,6-dideoxy-beta-L-idopyranosyl-(1->3)-beta-D-ribofuranosyl]oxy]cyclohexyl2-amino-2,3-dideoxy-;Anoside;AntibioticSF767AInChI:InChI=1/C29H55N5O18/c30-3-11-23(51-28-20(43)19(42)17(40)13(5-36)47-28)18(41)15(34)27(45-11)50-24-14(6-37)48-29(21(24)44)52-25-16(39)7(31)1-8(32)22(25)49-26-9(33)2-10(38)12(4-35)46-26/h7-29,35-44H,1-6,30-34H2/t7-,8+,9-,10+,11+,12-,13-,14-,15-,16+,17-,18-,19+,20+,21-,22-,23-,24-,25-,26-,27-,28-,29+/m1/s1CASNO:11111-23-2MolecularFormula:C29H55N5O18MolecularWeight:761.7697MolecularStructure:IndexofRefraction:1.675SurfaceTension:106.8dyne/cmDensity:1.65g/cm3FlashPoint:599.8°CEnthalpyofVaporization:177.12kJ/molBoilingPoint:1068.2°Cat760mmHgVapourPressure:0mmHgat25°C
Toxicity Data With Reference
| Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
|---|---|---|---|---|---|
| mouse | LD50 | intramuscular | 1348mg/kg (1348mg/kg) | BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION | Oyo Yakuri. Pharmacometrics. Vol. 6, Pg. 787, 1972. |
| mouse | LD50 | intravenous | 225mg/kg (225mg/kg) | SENSE ORGANS AND SPECIAL SENSES: "RETINAL CHANGES (PIGMENTARY DEPOSITIONS, RETINITIS, OTHER): EYE" BEHAVIORAL: MUSCLE WEAKNESS LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION | Oyo Yakuri. Pharmacometrics. Vol. 6, Pg. 787, 1972. |
| mouse | LD50 | oral | > 10gm/kg (10000mg/kg) | Oyo Yakuri. Pharmacometrics. Vol. 6, Pg. 787, 1972. | |
| mouse | LD50 | subcutaneous | 1249mg/kg (1249mg/kg) | BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD | Oyo Yakuri. Pharmacometrics. Vol. 6, Pg. 787, 1972. |
| rat | LD50 | intramuscular | 1750mg/kg (1750mg/kg) | BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION | Oyo Yakuri. Pharmacometrics. Vol. 6, Pg. 787, 1972. |
| rat | LD50 | intravenous | 365mg/kg (365mg/kg) | BEHAVIORAL: MUSCLE WEAKNESS LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION | Oyo Yakuri. Pharmacometrics. Vol. 6, Pg. 787, 1972. |
| rat | LD50 | oral | > 10gm/kg (10000mg/kg) | Oyo Yakuri. Pharmacometrics. Vol. 6, Pg. 787, 1972. | |
| rat | LD50 | subcutaneous | 1819mg/kg (1819mg/kg) | BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION | Oyo Yakuri. Pharmacometrics. Vol. 6, Pg. 787, 1972. |
Well-known Company Product Price
| Brand | (Code)Product description | CAS number | Packaging | Price | Detail |
|---|
Post a RFQ